174 related articles for article (PubMed ID: 21844871)
21. Impact of Co-transfection with Livin and survivin shRNA expression vectors on biological behavior of HepG2 cells.
Xu W; Chang H; Qin CK; Zhai YP
Asian Pac J Cancer Prev; 2013; 14(9):5467-72. PubMed ID: 24175843
[TBL] [Abstract][Full Text] [Related]
22. Fish-Oil-Derived DHA-mediated Enhancement of Apoptosis in Acute Lymphoblastic Leukemia Cells is Associated with Accumulation of p53, Downregulation of Survivin, and Caspase-3 Activation.
Sam MR; Esmaeillou M; Shokrgozar MA
Nutr Cancer; 2017 Jan; 69(1):64-73. PubMed ID: 27880058
[TBL] [Abstract][Full Text] [Related]
23. Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia.
Te Kronnie G; Bicciato S; Franceschini L; Accordi B; Dellíorto MC; Rinaldi A; Pession A; Barisone E; Conter V; Locatelli F; Basso G
Oncol Rep; 2006 Feb; 15(2):341-6. PubMed ID: 16391852
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance.
Lei Y; Geng Z; Guo-Jun W; He W; Jian-Lin Y
Mol Cell Biochem; 2010 Nov; 344(1-2):23-31. PubMed ID: 20563741
[TBL] [Abstract][Full Text] [Related]
25. Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents.
Trabulo S; Cardoso AM; Santos-Ferreira T; Cardoso AL; Simões S; Pedroso de Lima MC
Mol Pharm; 2011 Aug; 8(4):1120-31. PubMed ID: 21619051
[TBL] [Abstract][Full Text] [Related]
26. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
27. [Expression of survivin and its location in bone marrow cells of childhood acute leukemia: relationship to therapeutic efficacy].
Hou Y; Hu Q; Liu AG; Zhang LQ; Liu SY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):101-4. PubMed ID: 16613699
[TBL] [Abstract][Full Text] [Related]
28. [Inhibitory effect of short hairpin RNA targeting survivin gene on human ectopic endometrial cells].
Peng DX; He YL; Qiu LW
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):859-62. PubMed ID: 20423866
[TBL] [Abstract][Full Text] [Related]
29. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
30. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
31. A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.
Ling X; Cao S; Cheng Q; Keefe JT; Rustum YM; Li F
PLoS One; 2012; 7(9):e45571. PubMed ID: 23029106
[TBL] [Abstract][Full Text] [Related]
32. Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non‑small cell lung cancer cells.
Huang Q; Zeng Y; Lin H; Zhang H; Yang D
Mol Med Rep; 2017 Nov; 16(5):7086-7091. PubMed ID: 28901499
[TBL] [Abstract][Full Text] [Related]
33. Antisense inhibition of survivin expression as a cancer therapeutic.
Carrasco RA; Stamm NB; Marcusson E; Sandusky G; Iversen P; Patel BK
Mol Cancer Ther; 2011 Feb; 10(2):221-32. PubMed ID: 21216939
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells.
Zhu N; Gu L; Li F; Zhou M
Mol Cancer Ther; 2008 May; 7(5):1101-9. PubMed ID: 18483299
[TBL] [Abstract][Full Text] [Related]
35. Silencing of Notch3 Using shRNA driven by survivin promoter inhibits growth and promotes apoptosis of human T-cell acute lymphoblastic leukemia cells.
Xiang J; Ouyang Y; Cui Y; Lin F; Ren J; Long M; Chen X; Wei J; Zhang H
Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):59-65. PubMed ID: 21940234
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
37. Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.
George J; Banik NL; Ray SK
Neuro Oncol; 2010 Nov; 12(11):1088-101. PubMed ID: 20679253
[TBL] [Abstract][Full Text] [Related]
38. [Influence of short hairpin RNA on survivin mRNA expression and chemosensitivity to paclitaxel in ovarian cancer cells].
Yan XJ; Liang LZ; Zeng ZY; Fu LW; Shi Z
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):609-13. PubMed ID: 16202317
[TBL] [Abstract][Full Text] [Related]
39. Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.
Kim HJ; Choi EJ; Sohn HJ; Park SH; Min WS; Kim TG
Eur J Haematol; 2013 Nov; 91(5):411-22. PubMed ID: 23826993
[TBL] [Abstract][Full Text] [Related]
40. IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes.
Nakagawa Y; Abe S; Kurata M; Hasegawa M; Yamamoto K; Inoue M; Takemura T; Suzuki K; Kitagawa M
Am J Hematol; 2006 Nov; 81(11):824-31. PubMed ID: 16929535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]